David Parker
About David Parker
David Parker serves as the Senior IP Counsel at Canary Medical Inc., bringing extensive experience in intellectual property management from his previous roles, including Vice President of Intellectual Property at Angiotech and Partner at Seed IP Law Group.
Work at Canary Medical
David Parker has been serving as Senior IP Counsel at Canary Medical Inc. since 2021. In this role, he focuses on managing and protecting the company's intellectual property assets. His responsibilities include overseeing IP strategy and ensuring compliance with legal standards in the medical technology sector. His experience in this position contributes to the company's innovation and development in medical devices.
Previous Experience at Angiotech
Prior to his current role, David Parker worked at Angiotech as Vice President of Intellectual Property from 2003 to 2008. During his five years in this leadership position, he managed the company's intellectual property portfolio, which involved strategic planning and execution of IP initiatives. His work at Angiotech provided him with significant experience in the medical technology field.
Experience at Seed IP Law Group
David Parker was a Partner at Seed IP Law Group from 1996 to 2003. His seven years in this role involved providing legal counsel on various intellectual property matters. This position allowed him to develop expertise in managing IP portfolios and advising clients on legal strategies related to intellectual property.
Education and Expertise
David Parker holds a Ph.D. in Chemistry from the University of Oregon, where he studied from 1980 to 1985. He also earned a J.D. from Temple University - James E. Beasley School of Law between 1989 and 1993. Additionally, he obtained a B.S. in Chemistry from UCLA from 1975 to 1979. His educational background supports his expertise in handling intellectual property matters related to chemical, biochemical, medical, and biotechnology inventions.
Background in Intellectual Property Law
David Parker has been involved in the legal aspects of intellectual property since at least 1996. His extensive experience in this field encompasses various roles that have contributed to his understanding of IP management and strategy. His background enables him to effectively navigate the complexities of intellectual property law, particularly in the context of scientific and medical innovations.